{"id":6341,"date":"2020-12-08T22:25:00","date_gmt":"2020-12-08T21:25:00","guid":{"rendered":"https:\/\/www.osatzen.com\/blogs\/colchicina-a-dosis-bajas-en-pacientes-con-enfermedad-coronaria-cronica\/"},"modified":"2021-06-14T09:19:15","modified_gmt":"2021-06-14T07:19:15","slug":"colchicina-a-dosis-bajas-en-pacientes-con-enfermedad-coronaria-cronica","status":"publish","type":"post","link":"https:\/\/www.osatzen.com\/eu\/blogs\/colchicina-a-dosis-bajas-en-pacientes-con-enfermedad-coronaria-cronica\/","title":{"rendered":"\u00bfColchicina a dosis bajas en pacientes con enfermedad coronaria cr\u00f3nica?"},"content":{"rendered":"<div style=\"text-align: left;\">\u00a0<\/div>\n<div style=\"text-align: left;\"><span style=\"font-family: arial;\"> La pregunta en <b>formato PICO:<\/b>\u00a0<\/span><\/div>\n<div style=\"text-align: left;\">\n<ul>\n<li style=\"text-align: justify;\"><span style=\"font-family: arial;\"><b>Paciente<\/b>: De 35-82 a\u00f1os con Enfermedad Coronaria cl\u00ednicamente estable &gt;6meses. Excluyen personas con Insuficiencia renal moderada-severa, enfermedad valvular severa e Insuficiencia cardiaca severa.\u00a0<\/span><\/li>\n<li style=\"text-align: justify;\"><span style=\"font-family: arial;\"><b>Intervenci\u00f3n\/Comparaci\u00f3n<\/b>: Colchicina 0.5mg\/d\u00eda vs placebo id\u00e9ntico.\u00a0<\/span><\/li>\n<li style=\"text-align: justify;\"><span style=\"font-family: arial;\"><b>Variable de resultado principal<\/b>: combinada de mortalidad cardiovascular e infarto de miocardio y ACVA no mortal o revascularizaci\u00f3n coronaria\u00a0<\/span><\/li>\n<\/ul>\n<div style=\"text-align: justify;\"><span style=\"font-family: arial;\"><b>Las conclusiones<\/b>: La colchicina a\u00f1adida al tratamiento habitual se perfila como eficaz en prevenci\u00f3n secundaria de la cardiopat\u00eda isqu\u00e9mica. Queremos remarcar que, por ahora , es el \u00fanico ensayo cl\u00ednico de calidad sobre el tema. Esperamos que los estudios actualmente en marcha aporten luz definitiva sobre el papel de la colchicina en la enfermedad cardiovascular.\u00a0<\/span><\/div>\n<div style=\"text-align: justify;\"><span style=\"font-family: arial;\">\u00a0<\/span><\/div>\n<div style=\"text-align: justify;\"><span style=\"font-family: arial;\">Abajo, el CAT ( Critical Apraisal Topic) del ECA LoDoCo2.<\/span><\/div>\n<div style=\"text-align: justify;\">\u00a0<\/div>\n<\/div>\n<h3 style=\"text-align: left;\"><span style=\"font-family: arial;\"><b><span style=\"color: #cc0000;\">Koltxizina dosi baxuetan koronarioen gaixotasun kronikoan?<\/span><\/b>\u00a0<\/span><\/h3>\n<div style=\"text-align: left;\">\n<ul>\n<li style=\"text-align: justify;\"><span style=\"font-family: arial;\"><b>Gaixoak<\/b>: 35-82 arteko adinarekin. 6 hilabete baino gehiago klinikoki egonkorra den koronarioen gaixotasunarekin. Kanporaketak :Giltzurruneko gutxiegitasun ertain-larria daukatenak, bihotzeko balbulen gaixotasun larria daukatenak eta bihotzeko gutxiegitasun larria daukatenak.\u00a0<\/span><\/li>\n<li style=\"text-align: justify;\"><span style=\"font-family: arial;\"><b>Interbentzioa\/alderaketa<\/b>: koltxizina 0.5mg\/egunean vs plazebo itxura berdinarekin.\u00a0<\/span><\/li>\n<li style=\"text-align: justify;\"><span style=\"font-family: arial;\"><b>Aldagai nagusia<\/b> : hilkortasun kardiobaskularra, miokardioko infartua, garuneko hodietako istripua ez hilgarria edo birbaskularizazio koronarioa.\u00a0<\/span><\/li>\n<\/ul>\n<div style=\"text-align: justify;\"><b><u>Konklusioak:<\/u> <\/b>Koltxizina ohiko tratamendura gehitzen badiogu, eraginkorra dirudi koronarioen<\/div>\n<\/div>\n<div style=\"text-align: justify;\"><span style=\"font-family: arial;\">gaixotasuneko bigarren mailako prebentzioan. Oraingoz, gai honi buruzko kalitate oneko entsegu kliniko bakarra dela azpimarratu nahiko genuke. Abian dauden entsegu kliniko berriek, gaixotasun karidobaskularretan Koltxizinak duen erabateko papera argituko dutelakoan gaude.<\/span><\/div>\n<div style=\"text-align: justify;\"><span style=\"font-family: arial;\">Hau LoDoCo2 saiakuntza klinikoaren CAT (Critical Apraisal Topic) da.<\/span><\/div>\n<div style=\"text-align: justify;\"><span style=\"font-family: arial;\">\u00a0<\/span><\/div>\n<div style=\"text-align: justify;\"><span style=\"font-family: arial;\">\u00a0<\/span><\/div>\n<div style=\"text-align: center;\"><span style=\"font-family: arial;\">\u00a0<\/span><\/div>\n<div style=\"text-align: center;\"><iframe style=\"height: 1000px; width: 600px;\" src=\"https:\/\/docs.google.com\/document\/d\/e\/2PACX-1vRyPx3mGCiLaUTLz-car9iVyhh0NaSx1nEAIvqKAmd6wXRMN7ui-05r1KOeANfQDyCidqdFJxooq1OL\/pub?embedded=true\" frameborder=\"0\"><\/iframe><\/div>\n","protected":false},"excerpt":{"rendered":"<p>\u00a0 La pregunta en formato PICO:\u00a0 Paciente: De 35-82 a\u00f1os con Enfermedad Coronaria cl\u00ednicamente estable &gt;6meses. Excluyen personas con Insuficiencia renal moderada-severa, enfermedad valvular severa e Insuficiencia cardiaca severa.\u00a0 Intervenci\u00f3n\/Comparaci\u00f3n: Colchicina 0.5mg\/d\u00eda vs placebo id\u00e9ntico.\u00a0  [&#8230;]<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_eb_attr":"","footnotes":""},"categories":[624,580,579,581],"tags":[],"class_list":["post-6341","post","type-post","status-publish","format-standard","hentry","category-blog-salabardo-mbe","category-cat","category-colchicina","category-lectura-critica"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.3 (Yoast SEO v25.3) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>\u00bfColchicina a dosis bajas en pacientes con enfermedad coronaria cr\u00f3nica? - Osatzen<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.osatzen.com\/eu\/blogs\/colchicina-a-dosis-bajas-en-pacientes-con-enfermedad-coronaria-cronica\/\" \/>\n<meta property=\"og:locale\" content=\"eu_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u00bfColchicina a dosis bajas en pacientes con enfermedad coronaria cr\u00f3nica?\" \/>\n<meta property=\"og:description\" content=\"\u00a0 La pregunta en formato PICO:\u00a0 Paciente: De 35-82 a\u00f1os con Enfermedad Coronaria cl\u00ednicamente estable &gt;6meses. Excluyen personas con Insuficiencia renal moderada-severa, enfermedad valvular severa e Insuficiencia cardiaca severa.\u00a0 Intervenci\u00f3n\/Comparaci\u00f3n: Colchicina 0.5mg\/d\u00eda vs placebo id\u00e9ntico.\u00a0 [...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.osatzen.com\/eu\/blogs\/colchicina-a-dosis-bajas-en-pacientes-con-enfermedad-coronaria-cronica\/\" \/>\n<meta property=\"og:site_name\" content=\"Osatzen\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Osatzen\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-08T21:25:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-06-14T07:19:15+00:00\" \/>\n<meta name=\"author\" content=\"BLOG EL SALABARDO - MBE\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@osatzen\" \/>\n<meta name=\"twitter:site\" content=\"@osatzen\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"BLOG EL SALABARDO - MBE\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.osatzen.com\/eu\/blogs\/colchicina-a-dosis-bajas-en-pacientes-con-enfermedad-coronaria-cronica\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.osatzen.com\/eu\/blogs\/colchicina-a-dosis-bajas-en-pacientes-con-enfermedad-coronaria-cronica\/\"},\"author\":{\"name\":\"BLOG EL SALABARDO - MBE\",\"@id\":\"https:\/\/www.osatzen.com\/eu\/#\/schema\/person\/59f76d6c5831dff8ca4050643ea3aedb\"},\"headline\":\"\u00bfColchicina a dosis bajas en pacientes con enfermedad coronaria cr\u00f3nica?\",\"datePublished\":\"2020-12-08T21:25:00+00:00\",\"dateModified\":\"2021-06-14T07:19:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.osatzen.com\/eu\/blogs\/colchicina-a-dosis-bajas-en-pacientes-con-enfermedad-coronaria-cronica\/\"},\"wordCount\":247,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.osatzen.com\/eu\/#organization\"},\"articleSection\":[\"BLOG SALABARDO MBE\",\"CAT\",\"colchicina\",\"lectura cr\u00edtica\"],\"inLanguage\":\"eu-ES\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.osatzen.com\/eu\/blogs\/colchicina-a-dosis-bajas-en-pacientes-con-enfermedad-coronaria-cronica\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.osatzen.com\/eu\/blogs\/colchicina-a-dosis-bajas-en-pacientes-con-enfermedad-coronaria-cronica\/\",\"url\":\"https:\/\/www.osatzen.com\/eu\/blogs\/colchicina-a-dosis-bajas-en-pacientes-con-enfermedad-coronaria-cronica\/\",\"name\":\"\u00bfColchicina a dosis bajas en pacientes con enfermedad coronaria cr\u00f3nica? - Osatzen\",\"isPartOf\":{\"@id\":\"https:\/\/www.osatzen.com\/eu\/#website\"},\"datePublished\":\"2020-12-08T21:25:00+00:00\",\"dateModified\":\"2021-06-14T07:19:15+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.osatzen.com\/eu\/blogs\/colchicina-a-dosis-bajas-en-pacientes-con-enfermedad-coronaria-cronica\/#breadcrumb\"},\"inLanguage\":\"eu-ES\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.osatzen.com\/eu\/blogs\/colchicina-a-dosis-bajas-en-pacientes-con-enfermedad-coronaria-cronica\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.osatzen.com\/eu\/blogs\/colchicina-a-dosis-bajas-en-pacientes-con-enfermedad-coronaria-cronica\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.osatzen.com\/eu\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u00bfColchicina a dosis bajas en pacientes con enfermedad coronaria cr\u00f3nica?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.osatzen.com\/eu\/#website\",\"url\":\"https:\/\/www.osatzen.com\/eu\/\",\"name\":\"Osatzen\",\"description\":\"Sociedad Vasca de Medicina de Familia y Comunitaria\",\"publisher\":{\"@id\":\"https:\/\/www.osatzen.com\/eu\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.osatzen.com\/eu\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"eu-ES\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.osatzen.com\/eu\/#organization\",\"name\":\"Osatzen\",\"url\":\"https:\/\/www.osatzen.com\/eu\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"eu-ES\",\"@id\":\"https:\/\/www.osatzen.com\/eu\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.osatzen.com\/wp-content\/uploads\/2021\/02\/signo-distintivo-osatzen-2020-web-retina-396x120-1.png\",\"contentUrl\":\"https:\/\/www.osatzen.com\/wp-content\/uploads\/2021\/02\/signo-distintivo-osatzen-2020-web-retina-396x120-1.png\",\"width\":396,\"height\":120,\"caption\":\"Osatzen\"},\"image\":{\"@id\":\"https:\/\/www.osatzen.com\/eu\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Osatzen\",\"https:\/\/x.com\/osatzen\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.osatzen.com\/eu\/#\/schema\/person\/59f76d6c5831dff8ca4050643ea3aedb\",\"name\":\"BLOG EL SALABARDO - MBE\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"eu-ES\",\"@id\":\"https:\/\/www.osatzen.com\/eu\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/171995959dfb68f254c8e7f166f8edd042498aedcfa552b2137213520c305714?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/171995959dfb68f254c8e7f166f8edd042498aedcfa552b2137213520c305714?s=96&d=mm&r=g\",\"caption\":\"BLOG EL SALABARDO - MBE\"},\"description\":\"La idea de este blog es favorecer la ense\u00f1anza y pr\u00e1ctica de la medicina basada en la evidencia (MBE) . En \u00e9l podr\u00e1n encontrarse materiales elaborados por el grupo MBE Osatzen en forma de respuestas a dudas cl\u00ednicas y metodol\u00f3gicas, evaluaciones de art\u00edculos originales, etc, Pero el blog podr\u00e1 recoger cualquier otra iniciativa de inter\u00e9s relacionada con la mejora de la pr\u00e1ctica cl\u00ednica en atenci\u00f3n primaria.\",\"url\":\"https:\/\/www.osatzen.com\/eu\/blogs\/author\/blogelsalabardo\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"\u00bfColchicina a dosis bajas en pacientes con enfermedad coronaria cr\u00f3nica? - Osatzen","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.osatzen.com\/eu\/blogs\/colchicina-a-dosis-bajas-en-pacientes-con-enfermedad-coronaria-cronica\/","og_locale":"eu_ES","og_type":"article","og_title":"\u00bfColchicina a dosis bajas en pacientes con enfermedad coronaria cr\u00f3nica?","og_description":"\u00a0 La pregunta en formato PICO:\u00a0 Paciente: De 35-82 a\u00f1os con Enfermedad Coronaria cl\u00ednicamente estable &gt;6meses. Excluyen personas con Insuficiencia renal moderada-severa, enfermedad valvular severa e Insuficiencia cardiaca severa.\u00a0 Intervenci\u00f3n\/Comparaci\u00f3n: Colchicina 0.5mg\/d\u00eda vs placebo id\u00e9ntico.\u00a0 [...]","og_url":"https:\/\/www.osatzen.com\/eu\/blogs\/colchicina-a-dosis-bajas-en-pacientes-con-enfermedad-coronaria-cronica\/","og_site_name":"Osatzen","article_publisher":"https:\/\/www.facebook.com\/Osatzen","article_published_time":"2020-12-08T21:25:00+00:00","article_modified_time":"2021-06-14T07:19:15+00:00","author":"BLOG EL SALABARDO - MBE","twitter_card":"summary_large_image","twitter_creator":"@osatzen","twitter_site":"@osatzen","twitter_misc":{"Written by":"BLOG EL SALABARDO - MBE","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.osatzen.com\/eu\/blogs\/colchicina-a-dosis-bajas-en-pacientes-con-enfermedad-coronaria-cronica\/#article","isPartOf":{"@id":"https:\/\/www.osatzen.com\/eu\/blogs\/colchicina-a-dosis-bajas-en-pacientes-con-enfermedad-coronaria-cronica\/"},"author":{"name":"BLOG EL SALABARDO - MBE","@id":"https:\/\/www.osatzen.com\/eu\/#\/schema\/person\/59f76d6c5831dff8ca4050643ea3aedb"},"headline":"\u00bfColchicina a dosis bajas en pacientes con enfermedad coronaria cr\u00f3nica?","datePublished":"2020-12-08T21:25:00+00:00","dateModified":"2021-06-14T07:19:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.osatzen.com\/eu\/blogs\/colchicina-a-dosis-bajas-en-pacientes-con-enfermedad-coronaria-cronica\/"},"wordCount":247,"commentCount":0,"publisher":{"@id":"https:\/\/www.osatzen.com\/eu\/#organization"},"articleSection":["BLOG SALABARDO MBE","CAT","colchicina","lectura cr\u00edtica"],"inLanguage":"eu-ES","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.osatzen.com\/eu\/blogs\/colchicina-a-dosis-bajas-en-pacientes-con-enfermedad-coronaria-cronica\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.osatzen.com\/eu\/blogs\/colchicina-a-dosis-bajas-en-pacientes-con-enfermedad-coronaria-cronica\/","url":"https:\/\/www.osatzen.com\/eu\/blogs\/colchicina-a-dosis-bajas-en-pacientes-con-enfermedad-coronaria-cronica\/","name":"\u00bfColchicina a dosis bajas en pacientes con enfermedad coronaria cr\u00f3nica? - Osatzen","isPartOf":{"@id":"https:\/\/www.osatzen.com\/eu\/#website"},"datePublished":"2020-12-08T21:25:00+00:00","dateModified":"2021-06-14T07:19:15+00:00","breadcrumb":{"@id":"https:\/\/www.osatzen.com\/eu\/blogs\/colchicina-a-dosis-bajas-en-pacientes-con-enfermedad-coronaria-cronica\/#breadcrumb"},"inLanguage":"eu-ES","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.osatzen.com\/eu\/blogs\/colchicina-a-dosis-bajas-en-pacientes-con-enfermedad-coronaria-cronica\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.osatzen.com\/eu\/blogs\/colchicina-a-dosis-bajas-en-pacientes-con-enfermedad-coronaria-cronica\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.osatzen.com\/eu\/"},{"@type":"ListItem","position":2,"name":"\u00bfColchicina a dosis bajas en pacientes con enfermedad coronaria cr\u00f3nica?"}]},{"@type":"WebSite","@id":"https:\/\/www.osatzen.com\/eu\/#website","url":"https:\/\/www.osatzen.com\/eu\/","name":"Osatzen","description":"Sociedad Vasca de Medicina de Familia y Comunitaria","publisher":{"@id":"https:\/\/www.osatzen.com\/eu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.osatzen.com\/eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"eu-ES"},{"@type":"Organization","@id":"https:\/\/www.osatzen.com\/eu\/#organization","name":"Osatzen","url":"https:\/\/www.osatzen.com\/eu\/","logo":{"@type":"ImageObject","inLanguage":"eu-ES","@id":"https:\/\/www.osatzen.com\/eu\/#\/schema\/logo\/image\/","url":"https:\/\/www.osatzen.com\/wp-content\/uploads\/2021\/02\/signo-distintivo-osatzen-2020-web-retina-396x120-1.png","contentUrl":"https:\/\/www.osatzen.com\/wp-content\/uploads\/2021\/02\/signo-distintivo-osatzen-2020-web-retina-396x120-1.png","width":396,"height":120,"caption":"Osatzen"},"image":{"@id":"https:\/\/www.osatzen.com\/eu\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Osatzen","https:\/\/x.com\/osatzen"]},{"@type":"Person","@id":"https:\/\/www.osatzen.com\/eu\/#\/schema\/person\/59f76d6c5831dff8ca4050643ea3aedb","name":"BLOG EL SALABARDO - MBE","image":{"@type":"ImageObject","inLanguage":"eu-ES","@id":"https:\/\/www.osatzen.com\/eu\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/171995959dfb68f254c8e7f166f8edd042498aedcfa552b2137213520c305714?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/171995959dfb68f254c8e7f166f8edd042498aedcfa552b2137213520c305714?s=96&d=mm&r=g","caption":"BLOG EL SALABARDO - MBE"},"description":"La idea de este blog es favorecer la ense\u00f1anza y pr\u00e1ctica de la medicina basada en la evidencia (MBE) . En \u00e9l podr\u00e1n encontrarse materiales elaborados por el grupo MBE Osatzen en forma de respuestas a dudas cl\u00ednicas y metodol\u00f3gicas, evaluaciones de art\u00edculos originales, etc, Pero el blog podr\u00e1 recoger cualquier otra iniciativa de inter\u00e9s relacionada con la mejora de la pr\u00e1ctica cl\u00ednica en atenci\u00f3n primaria.","url":"https:\/\/www.osatzen.com\/eu\/blogs\/author\/blogelsalabardo\/"}]}},"_links":{"self":[{"href":"https:\/\/www.osatzen.com\/eu\/wp-json\/wp\/v2\/posts\/6341","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.osatzen.com\/eu\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.osatzen.com\/eu\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.osatzen.com\/eu\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.osatzen.com\/eu\/wp-json\/wp\/v2\/comments?post=6341"}],"version-history":[{"count":2,"href":"https:\/\/www.osatzen.com\/eu\/wp-json\/wp\/v2\/posts\/6341\/revisions"}],"predecessor-version":[{"id":6552,"href":"https:\/\/www.osatzen.com\/eu\/wp-json\/wp\/v2\/posts\/6341\/revisions\/6552"}],"wp:attachment":[{"href":"https:\/\/www.osatzen.com\/eu\/wp-json\/wp\/v2\/media?parent=6341"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.osatzen.com\/eu\/wp-json\/wp\/v2\/categories?post=6341"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.osatzen.com\/eu\/wp-json\/wp\/v2\/tags?post=6341"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}